Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1

Status

Recruiting 6Active not recruiting 6Not yet recruiting 4Completed 3Unknown 2Terminated 2Withdrawn 1

Sponsor Class

OTHER 4

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Gastrointestinal 8Thoracic 5Gynecologic 4Lymphoid 3Head & Neck 3Endocrine 2Tumor-Agnostic 1Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Endometrial Neoplasms 3Uterine Cervical Neoplasms 1

Interventions

Paclitaxel 24Carboplatin 18Bevacizumab 14Cisplatin 10pembrolizumab 7fluzoparib 7Radiotherapy 6Drug Therapy 6apatinib 5Topotecan 5Magnetic Resonance Spectroscopy 5Injections 5liposomal doxorubicin 4lenvatinib 4famitinib 4camrelizumab 4Tirzepatide 4Specimen Handling 4Platinum 4Observation 4Gemcitabine 4Brachytherapy 4toripalimab 3olaparib 3dostarlimab 3anlotinib 3Watchful Waiting 3Therapeutics 3Surveys and Questionnaires 3Neoadjuvant Therapy 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Not yet recruiting × Observation × Gynecologic × Clear all
NCT07281547 2026-02-18

Low Dose Aspirin to Lower Inflammation and Prevent Endometrial Cancer in Postmenopausal Women With Non-atrophic Endometrial Changes and Pain

Mayo Clinic

Phase 4 Not yet recruiting
25 enrolled
Gynecologic

Endometrial Neoplasms

NCT06861855 2025-09-30

Prognosis of METTL-14 in Endometrial Carcinoma

Assiut University

Not yet recruiting
50 enrolled
Gynecologic

Endometrial Neoplasms

NCT06254729 2024-02-12

EECC

First Affiliated Hospital Xi'an Jiaotong University

Not yet recruiting
4,000 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT05524389 2022-11-23

Study of Early Stage Endometrial Cancer Based on Molecular Classification and Traditional Risk Stratification to Guide Adjuvant Radiotherapy Decisions

Peking Union Medical College Hospital

Phase 3 Not yet recruiting
624 enrolled
Gynecologic

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡